EUVIMEDEUVIMED entdecken
Kommentar

The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim

Hanny Al-Samkari iD, Alexandra Schifferli iD, Tomas J Gonzalez-Lopez iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19327 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Hanny Al-Samkari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Thrombocytopenia, Pyrazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia refractory to multiple thrombopoietin receptor agonists remains a challenging clinical problem. This commentary discusses and contextualizes the recent report on this entity from Moulis and colleagues, and how to move forward with these patients. Commentary on: Moulis et al. Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France Registry. Br J Haematol 2024;204:1476‐1482.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaPyrazolesAdultHumansReceptors, ThrombopoietinThrombopoietinBenzoatesHydrazinesReceptors, FcRecombinant Fusion Proteins

Stichwörter der Autor:innen

eltrombopagimmune thrombocytopeniarefractoryromiplostimthrombopoietin receptor agonist

Substanzen

romiplostimeltrombopagReceptors, ThrombopoietinThrombopoietinBenzoatesHydrazinesReceptors, FcRecombinant Fusion ProteinsPyrazoles

Autor:innen und Institutionen

  • Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland.
  • Hematology Department, Hospital Universitario de Burgos, Burgos, Spain.

ORCID-Profile: Hanny Al-Samkari, Alexandra Schifferli, Tomas J Gonzalez-Lopez

Zitieren

APA

Al-Samkari, H., Schifferli, A., & Gonzalez-Lopez, T. J. (2024). The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. British Journal of Haematology. https://doi.org/10.1111/bjh.19327

Vancouver

Al-Samkari H, Schifferli A, Gonzalez-Lopez TJ. The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. British Journal of Haematology. 2024. doi:10.1111/bjh.19327

BibTeX
@article{AlSamkari2024,
  author = {Al-Samkari, Hanny and Schifferli, Alexandra and Gonzalez-Lopez, Tomas J},
  title = {The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19327}
}
Kostenlos starten →